Back

Association of computed tomography scan-assessed body composition with immune and PI3K/AKT pathway proteins in distinct breast cancer tumor components

Cheng, T.-Y. D.; Fu, D. A.; Falzarano, S. M.; Zhang, R.; Datta, S.; Zhang, W.; Omilian, A.; Aduse-Poku, L.; Bian, J.; Irianto, J.; Asirvatham, J. R.; Campbell-Thompson, M.

2024-05-22 epidemiology
10.1101/2024.05.21.24307688 medRxiv
Show abstract

This hypothesis-generating study aims to examine the extent to which computed tomography-assessed body composition phenotypes are associated with immune and PI3K/AKT signaling pathways in breast tumors. A total of 52 patients with newly diagnosed breast cancer were classified into four body composition types: adequate (lowest two tertiles of total adipose tissue [TAT]) and highest two tertiles of total skeletal muscle [TSM] areas); high adiposity (highest tertile of TAT and highest two tertiles of TSM); low muscle (lowest tertile of TSM and lowest two tertiles of TAT); and high adiposity with low muscle (highest tertile of TAT and lowest tertile of TSM). Immune and PI3K/AKT pathway proteins were profiled in tumor epithelium and the leukocyte-enriched stromal microenvironment using GeoMx (NanoString). Linear mixed models were used to compare log2-transformed protein levels. Compared with the normal type, the low muscle type was associated with higher expression of INPP4B (log2-fold change = 1.14, p = 0.0003, false discovery rate = 0.028). Other significant associations included low muscle type with increased CTLA4 and decreased pan-AKT expression in tumor epithelium, and high adiposity with increased CD3, CD8, CD20, and CD45RO expression in stroma (P<0.05; false discovery rate >0.2). With confirmation, body composition can be associated with signaling pathways in distinct components of breast tumors, highlighting the potential utility of body composition in informing tumor biology and therapy efficacies.

Matching journals

The top 2 journals account for 50% of the predicted probability mass.

1
Breast Cancer Research
32 papers in training set
Top 0.1%
34.2%
2
JNCI Cancer Spectrum
10 papers in training set
Top 0.1%
23.4%
50% of probability mass above
3
Scientific Reports
3102 papers in training set
Top 21%
5.0%
4
International Journal of Cancer
42 papers in training set
Top 0.2%
4.8%
5
Cancers
200 papers in training set
Top 1%
4.5%
6
Cancer Epidemiology, Biomarkers & Prevention
17 papers in training set
Top 0.2%
3.2%
7
PLOS ONE
4510 papers in training set
Top 51%
1.9%
8
BMC Cancer
52 papers in training set
Top 1%
1.9%
9
Frontiers in Cell and Developmental Biology
218 papers in training set
Top 4%
1.8%
10
JNCI: Journal of the National Cancer Institute
16 papers in training set
Top 0.4%
1.4%
11
eBioMedicine
130 papers in training set
Top 2%
1.3%
12
Frontiers in Immunology
586 papers in training set
Top 5%
1.3%
13
Annals of Oncology
13 papers in training set
Top 0.7%
1.0%
14
Frontiers in Endocrinology
53 papers in training set
Top 2%
0.9%
15
eLife
5422 papers in training set
Top 56%
0.8%
16
Nature Communications
4913 papers in training set
Top 62%
0.8%
17
Cell Reports Medicine
140 papers in training set
Top 8%
0.7%
18
Communications Biology
886 papers in training set
Top 24%
0.7%
19
Human Molecular Genetics
130 papers in training set
Top 4%
0.7%
20
Physiological Reports
35 papers in training set
Top 1%
0.7%
21
British Journal of Cancer
42 papers in training set
Top 2%
0.5%
22
Journal of Clinical Medicine
91 papers in training set
Top 8%
0.5%